Checkpoint inhibitor use is exploding in cancer Rx. Big data review of 13000 cases of immune mediated reactions are mostly endo, GI and pulmonary and NOT rheumatic THUS0628 #EULAR2019 @RheumNow https://t.co/iYO8t6ALBx